These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19893556)

  • 1. Attacking the flu: neutralizing antibodies may lead to 'universal' vaccine.
    Chen GL; Subbarao K
    Nat Med; 2009 Nov; 15(11):1251-2. PubMed ID: 19893556
    [No Abstract]   [Full Text] [Related]  

  • 2. Call for a paradigm shift in the design of universal influenza vaccines by harnessing multiple correlates of protection.
    Jang YH; Seong BL
    Expert Opin Drug Discov; 2020 Dec; 15(12):1441-1455. PubMed ID: 32783765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Universal flu vaccine is 'an alchemist's dream'.
    Cohen J
    Science; 2018 Dec; 362(6419):1094. PubMed ID: 30523090
    [No Abstract]   [Full Text] [Related]  

  • 4. Stalking influenza diversity with a universal antibody.
    Russell CJ
    N Engl J Med; 2011 Oct; 365(16):1541-2. PubMed ID: 22010922
    [No Abstract]   [Full Text] [Related]  

  • 5. Modified vaccinia virus ankara (MVA) as production platform for vaccines against influenza and other viral respiratory diseases.
    Altenburg AF; Kreijtz JH; de Vries RD; Song F; Fux R; Rimmelzwaan GF; Sutter G; Volz A
    Viruses; 2014 Jul; 6(7):2735-61. PubMed ID: 25036462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tracking progress in universal influenza vaccine development.
    Ostrowsky J; Arpey M; Moore K; Osterholm M; Friede M; Gordon J; Higgins D; Molto-Lopez J; Seals J; Bresee J
    Curr Opin Virol; 2020 Feb; 40():28-36. PubMed ID: 32279026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of in vitro cross-reactivity to avian H5N1 and pandemic H1N1 2009 influenza following prime boost regimens of seasonal influenza vaccination in healthy human subjects: a randomised trial.
    Bethell D; Saunders D; Jongkaewwattana A; Kramyu J; Thitithayanont A; Wiboon-ut S; Yongvanitchit K; Limsalakpetch A; Kum-Arb U; Uthaimongkol N; Garcia JM; Timmermans AE; Peiris M; Thomas S; Engering A; Jarman RG; Mongkolsirichaikul D; Mason C; Khemnu N; Tyner SD; Fukuda MM; Walsh DS; Pichyangkul S
    PLoS One; 2013; 8(3):e59674. PubMed ID: 23555741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in the Development of Universal Influenza Vaccines.
    Sun W; Luo T; Liu W; Li J
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32957468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the immunogenicity and safety of different doses and formulations of a broad spectrum influenza vaccine (FLU-v) developed by SEEK: study protocol for a single-center, randomized, double-blind and placebo-controlled clinical phase IIb trial.
    van Doorn E; Pleguezuelos O; Liu H; Fernandez A; Bannister R; Stoloff G; Oftung F; Norley S; Huckriede A; Frijlink HW; Hak E
    BMC Infect Dis; 2017 Apr; 17(1):241. PubMed ID: 28376743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Vaccine Design and Delivery Technologies.
    Kanekiyo M; Ellis D; King NP
    J Infect Dis; 2019 Apr; 219(Suppl_1):S88-S96. PubMed ID: 30715361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric hemagglutinin vaccine elicits broadly protective CD4 and CD8 T cell responses against multiple influenza strains and subtypes.
    Liao HY; Wang SC; Ko YA; Lin KI; Ma C; Cheng TR; Wong CH
    Proc Natl Acad Sci U S A; 2020 Jul; 117(30):17757-17763. PubMed ID: 32669430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of protective immunity against influenza virus in a macaque model: comparison of conventional and iscom vaccines.
    Rimmelzwaan GF; Baars M; van Beek R; van Amerongen G; Lövgren-Bengtsson K; Claas EC; Osterhaus AD
    J Gen Virol; 1997 Apr; 78 ( Pt 4)():757-65. PubMed ID: 9129647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis of influenza virus neutralization.
    Han T; Marasco WA
    Ann N Y Acad Sci; 2011 Jan; 1217():178-90. PubMed ID: 21251008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why is the flu vaccine so mediocre?
    Cohen J
    Science; 2017 Sep; 357(6357):1222-1223. PubMed ID: 28935783
    [No Abstract]   [Full Text] [Related]  

  • 15. [Research progress and prospect of universal influenza vaccine].
    Luo DY; Xue CY; Cao YC
    Bing Du Xue Bao; 2013 Nov; 29(6):646-50. PubMed ID: 24520771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ["Should we vaccinate against the grippe?"].
    Paccaud MF
    Schweiz Med Wochenschr; 1978 Jan; 108(2):45-7. PubMed ID: 74850
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuraminidase: Another Piece of the Influenza Vaccine Puzzle.
    Eckard LE; Webby RJ
    J Infect Dis; 2015 Oct; 212(8):1180-1. PubMed ID: 25858958
    [No Abstract]   [Full Text] [Related]  

  • 18. Broadly protective influenza vaccines: design and production platforms.
    Elbahesh H; Saletti G; Gerlach T; Rimmelzwaan GF
    Curr Opin Virol; 2019 Feb; 34():1-9. PubMed ID: 30497050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommended composition of influenza virus vaccines for use in the 2004 influenza season.
    Wkly Epidemiol Rec; 2003 Oct; 78(43):375-9. PubMed ID: 14601331
    [No Abstract]   [Full Text] [Related]  

  • 20. Extra-Neutralizing FcR-Mediated Antibody Functions for a Universal Influenza Vaccine.
    Boudreau CM; Alter G
    Front Immunol; 2019; 10():440. PubMed ID: 30949165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.